Rigel Pharmaceuticals, Inc.

RIGL · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$48,534$53,407$45,728$56,746
Short-Term Investments$88,609$54,972$31,371$20,575
Receivables$45,925$39,907$41,547$41,615
Inventory$20,611$10,423$4,659$6,002
Other Curr. Assets$11,248$16,684$23,258$10,165
Total Curr. Assets$214,927$175,393$146,563$135,103
Property Plant & Equip (Net)$1,104$1,235$1,381$338
Goodwill$0$0$0$0
Intangibles$25,336$25,924$26,512$27,100
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,167$4,184$1,516$1,435
Total NC Assets$27,607$31,343$29,409$28,873
Other Assets$0$0$0$0
Total Assets$242,534$206,736$175,972$163,976
Liabilities
Payables$3,846$7,290$3,954$3,339
Short-Term Debt$30,355$22,878$15,271$7,557
Tax Payable$0$0$0$0
Deferred Revenue$0$30,857$1,355$27,795
Other Curr. Liab.$60,199$25,611$46,049$24,608
Total Curr. Liab.$94,400$86,636$66,629$63,299
LT Debt$30,525$38,166$45,795$52,408
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$44,981$44,981
Total NC Liab.$30,525$38,166$90,776$97,389
Other Liabilities$0$0$0$0
Cap. Leases$1,150$1,231$1,320$285
Total Liabilities$124,925$124,802$157,405$160,688
Equity
Pref Stock$0$0$0$0
Common Stock$18$18$18$18
Retained Earnings-$1,291,106-$1,319,006-$1,378,619-$1,390,065
AOCI$96$6-$2$10
Other Equity$1,408,601$1,400,916$1,397,170$1,393,325
Total Equity$117,609$81,934$18,567$3,288
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$242,534$206,736$175,972$163,976
Net Debt$12,346$7,637$15,338$3,219
Rigel Pharmaceuticals, Inc. (RIGL) Financial Statements & Key Stats | AlphaPilot